Holen Sie sich die Stockscreener-App
11.15
1.64%
0.18
Handel nachbörslich:
11.16
0.010
+0.09%
Ars Pharmaceuticals Inc Aktie (SPRY) Neueste Nachrichten
ARS Pharma’s neffy nasal spray approved in China... - The Pharma Letter
The Technical Signals Behind (SPRY) That Institutions Follow - Stock Traders Daily
ARS Pharmaceuticals Stock Pre-Market (+4.4%) : 'neffy' Nasal Spray Approved in China - Trefis
Is ARS Pharmaceuticals a buy? - Cantech Letter
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? - RTTNews
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
ARS Pharmaceuticals announces NMPA approval for neffy 2 mg - Yahoo Finance
ARS Pharmaceuticals Insiders Sold US$1.3m Of Shares Suggesting Hesitancy - simplywall.st
China approves first community use epinephrine nasal spray for allergies By Investing.com - Investing.com Nigeria
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 3.4%Time to Buy? - MarketBeat
ARS Pharma Receives Approval For Neffy In China, Expanding Global Reach - Nasdaq
ARS Pharmaceuticals Wins China Approval for First Community-Use Epinephrine for Allergic Reactions - marketscreener.com
China approves first community use epinephrine nasal spray for allergies - Investing.com
ARS Pharmaceuticals' neffy Approved as First Epinephrine Nasal Spray for Out-of-Hospital Use in China - Quiver Quantitative
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) - The Manila Times
Needle-free allergy rescue spray cleared in China for home use - Stock Titan
ARS Investment Partners LLC Increases Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Trading Systems Reacting to (SPRY) Volatility - Stock Traders Daily
Is ARS Pharmaceuticals Inc. stock cheap at current valuationJuly 2025 Highlights & Reliable Volume Spike Alerts - Улправда
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 7.9% HigherWhat's Next? - MarketBeat
Can ARS Pharmaceuticals Inc. stock hit record highs againJuly 2025 Setups & Verified Trade Idea Suggestions - Bölüm Sonu Canavarı
What insider trading reveals about ARS Pharmaceuticals Inc. stockMarket Performance Report & Daily Stock Trend Watchlist - Улправда
Is ARS Pharmaceuticals Inc. stock near bottom after declineMarket Sentiment Summary & High Conviction Investment Ideas - ulpravda.ru
ARS Pharmaceuticals Earnings Notes - Trefis
Avoiding Lag: Real-Time Signals in (SPRY) Movement - news.stocktradersdaily.com
ARS Pharmaceuticals signs agreement with ALK-Abelló A/S for neffy - MSN
ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 6.3%Time to Buy? - MarketBeat
Is ARS Pharmaceuticals Inc a good long term investmentStock Correlation Metrics & Investment Recommendations You Can Trust - earlytimes.in
Next Century Growth Investors LLC Makes New Investment in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
Ardsley Advisory Partners LP Boosts Stock Position in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ARS Pharmaceuticals (SPRY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How ARS Pharmaceuticals Inc. stock reacts to global recession fearsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
Why ARS Pharmaceuticals Inc. stock is favored by pension fundsPortfolio Update Report & Safe Capital Investment Plans - Newser
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1%Here's What Happened - MarketBeat
Is ARS Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Discipline and Rules-Based Execution in SPRY Response - news.stocktradersdaily.com
ARS Pharmaceuticals, Inc. $SPRY Shares Bought by Geode Capital Management LLC - MarketBeat
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts - Yahoo Finance
Steward Partners Investment Advisory LLC Raises Stock Position in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Takes $1.77 Million Position in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
ARS Pharmaceuticals, Inc. to Participate in Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative
ARS Pharmaceuticals (NASDAQ: SPRY) in fireside chat at Piper Sandler 37th Conference - Stock Titan
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - The Manila Times
ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research - MarketBeat
Behavioral Patterns of SPRY and Institutional Flows - news.stocktradersdaily.com
Is ARS Pharmaceuticals Inc. stock supported by strong fundamentals2025 Key Highlights & Precise Buy Zone Tips - newser.com
How ARS Pharmaceuticals Inc. stock valuations compare to rivalsMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com
Will ARS Pharmaceuticals Inc. stock maintain momentum in 2025Earnings Overview Summary & Consistent Growth Stock Picks - newser.com
How ARS Pharmaceuticals Inc. stock benefits from strong dollarPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Is ARS Pharmaceuticals Inc. stock supported by innovation pipelineQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com
Is ARS Pharmaceuticals Inc. a candidate for recovery play2025 Market Trends & Accurate Buy Signal Alerts - newser.com
Can ARS Pharmaceuticals Inc. hit a new high this monthJuly 2025 Summary & Fast Momentum Entry Tips - newser.com
ARS Pharmaceuticals Inc. stock outlook for YEARQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):